Vestcor Inc’s Profound Medical PROF Stock Holding History

Vestcor Inc’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,000	Closed	-$376K	–	1258
2024 Q4	$376K	Buy	+50,000	New	+$384K	0.01%	782

Other funds holding PROF

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vestcor Inc's PROF Position: Q1 2025 in Review

Vestcor Inc sold out of Profound Medical (PROF) in Q1 2025, closing a stake of 50,000 shares — an estimated $376K sold.

Vestcor Inc first reported a position in PROF in Q4 2024 and held it in 1 quarter. The position peaked at $376K in Q4 2024. 49 funds tracked by Wall St. Rank hold PROF as of Q1 2025.

Vestcor Inc reported no remaining Profound Medical position as of Q1 2025 after selling out during the quarter.
Vestcor Inc sold 50,000 Profound Medical shares in Q1 2025, an estimated $376K.
Vestcor Inc first reported a position in Profound Medical in Q4 2024 and held it in 1 quarter.
Vestcor Inc's Profound Medical position peaked at $376K in Q4 2024.
49 funds tracked by Wall St. Rank held Profound Medical as of Q1 2025.

Based on Vestcor Inc's 13F filing for Q1 2025, filed 8 May 2025.